Asahara T, Yano M, Fukuda S, Fukuda T, Nakahara H, Katayama K, Itamoto T, Dohi K, Nakanishi T, Kitamoto M, Azuma K, Ito K, Moriwaki K, Yuge O, Shimamoto F
Department of Surgery II, Hiroshima University School of Medicine, Japan.
Hiroshima J Med Sci. 1999 Sep;48(3):91-4.
Brain metastasis from hepatocellular carcinoma (HCC) is a rare, yet perplexing problem in patients with cancer. We report on 5 patients with metastasis of HCC to the brain after radical hepatectomy. Intrahepatic recurrence occurred in 3 patients, and distant metastasis to sites other than the brain was observed in 3 patients (lung, 2; bone, 1). The symptoms for brain metastasis included headache, hemiparesis, and vomiting. Hemorrhage was found in 4 of 5 patients. All patients had a single nodular lesion in the brain. The alpha-fetoprotein levels were more than 10,000 ng/ml in 4 patients. Two patients underwent surgical resection, 1 received cranial irradiation, and 2 were administered corticosteroids. The interval between diagnosis of the primary cancer and detection of brain metastasis ranged from 2 to 54 months. The mean survival period was only 3 months after diagnosis of brain metastasis. All 5 patients died of neurologic causes. Because no effective treatment for brain metastasis from HCC is available, further study is needed.
肝细胞癌(HCC)脑转移在癌症患者中是一个罕见但令人困惑的问题。我们报告了5例根治性肝切除术后发生HCC脑转移的患者。3例患者出现肝内复发,3例患者出现脑外远处转移(肺转移2例;骨转移1例)。脑转移的症状包括头痛、偏瘫和呕吐。5例患者中有4例发现出血。所有患者脑内均有单个结节性病变。4例患者的甲胎蛋白水平超过10000 ng/ml。2例患者接受了手术切除,1例接受了颅脑照射,2例接受了皮质类固醇治疗。从原发性癌症诊断到脑转移检测的间隔时间为2至54个月。脑转移诊断后的平均生存期仅为3个月。所有5例患者均死于神经原因。由于目前尚无针对HCC脑转移的有效治疗方法,因此需要进一步研究。